The Planning Board will investigate the 19 properties owned by Merck to determine if they qualify for redevelopment as the pharmaceutical giant plans to move its global headquarters within the next three years.
The Planning Board will investigate the 19 properties owned by Merck to determine if they qualify for redevelopment as the pharmaceutical giant plans to move its global headquarters within the next three years.